Brandshield wins new business contract with 'leading pharmaceutical company'
6th Apr 2022 10:00
(Sharecast News) - Cybersecurity group BrandShield Systems has secured a new business contract with an unnamed "leading pharmaceutical company".
Read moreBrandshield raises £1.5m via share placing
28th Jan 2022 07:46
(Sharecast News) - Cybersecurity firm Brandshield has raised gross proceeds of £1.5m from a placing of 10.71m new ordinary shares via an accelerated bookbuild process with an issue price of 14.0p per share.
Read moreBrandShield secures credit facility with Leumi Bank
4th Oct 2021 11:34
(Sharecast News) - Brand protection technology company BrandShield Systems has entered into an agreement with Leumi Bank to provide a revolving monthly recurring revenue (MRR) credit line facility of up to NIS 8m (£1.8m), it announced on Monday.
Read moreBrandshield secures SaaS contract with payment processing company
18th Aug 2021 07:22
(Sharecast News) - Software company Brandshield has secured a contract with an unnamed payment processing company, adding to the firm's growing number of clients in the financial services sector.
Read moreBrandshield scores contract with unnamed financial services firm
3rd Aug 2021 10:57
(Sharecast News) - Cybersecurity firm Brandshield Systems said on Tuesday that it had secured a contract with an unnamed customer in the financial services sector.
Read moreBrandshield Systems wins celebrity merchandise contract
13th Jul 2021 09:00
(Sharecast News) - Cybersecurity firm Brandshield Systems said on Tuesday that it had secured a contract in the celebrity merchandise sector.
Read moreBrandshield annual recurring revenues grow amid pandemic
11th Feb 2021 11:44
(Sharecast News) - Cybersecurity firm Brandshield Systems said on Thursday that it had seen a marked increase in annual recurring revenues in 2020.
Read moreBrandShield signs cybersecurity deal with Bristol Myers Squibb
21st Dec 2020 10:58
(Sharecast News) - Cybersecurity company BrandShield Systems has signed a contract to provide services to US-based biopharmaceutical giant Bristol Myers Squibb, it announced on Monday.
Read more